Sanicle: Why Researchers Are Suddenly Studying This Forgotten Woodland Plant Again

Few European woodland plants carry their reputation as openly in their name as sanicle. Sanicula derives from the Latin sanare – to heal. For centuries the inconspicuous member of the carrot family was a fixture in the herbals of the 16th and 17th centuries, then it all but vanished from view. Only in recent years have research groups in Vienna, Ivano-Frankivsk and Poznań taken a closer look again – and found something remarkable in a plant most walkers simply overlook.

The name reveals how highly this plant was once regarded

Wood sanicle (Sanicula europaea L.) belongs to the Apiaceae, the same family as carrot, fennel and lovage. At first glance you would hardly guess it: instead of the typical large, flat umbel it forms tiny spherical flower heads that look more like a miniature thistle. The fruits carry hooked bristles and cling to fur and trouser legs – hence folk names such as "wood burdock".

The genus Sanicula comprises around 50 species worldwide; in Central Europe essentially only S. europaea occurs. It is distributed across much of Europe and extends into Western Asia and North Africa. Its habitat is characteristic: shaded to partly shaded deciduous woodland, preferably beech and hornbeam forests on fresh, usually calcareous soils. Anyone walking through a Swiss beech wood is very likely to pass right by it.

The German name Sanikel derives, via the mediaeval Latin sanicula, from the Latin sanare – literally something like "the little healer". The many vernacular names speak for themselves too: fracture herb, healing umbel, wound sanicle, "heal-all-damage". Traditionally it was mainly the basal leaves, gathered during flowering and dried (Saniculae herba), that were used, and less frequently the rhizome and roots.

What modern analyses actually find in sanicle herb

In 2025 a research group at the University of Vienna placed the above-ground and below-ground parts of sanicle side by side for the first time and analysed them using thin-layer chromatography, HPLC and mass spectrometry. The result was strikingly clear, even to the researchers themselves: herb and root contain essentially the same two classes of compounds.

The first are hydroxycinnamic acid derivatives, above all rosmarinic acid – the dominant single compound by quantity in both plant parts. Alongside it come chlorogenic acid, a rosmarinic acid glycoside and 3,4-dicaffeoylquinic acid, which had not previously been described in the genus Sanicula at all. The second class are oleanane-type triterpene saponins, including compounds with a molecular mass around 1100 g/mol that most likely correspond to the known saniculosides. That these really are saponins was confirmed via their characteristic haemolytic behaviour on the chromatography plate.

A Ukrainian-Estonian group published a complementary analysis of aqueous and ethanolic extracts in the same year. It identified 16 phenolic compounds; the total phenolic content of the dry extracts ranged from 11.08 to 15.02 per cent. The difference between plant parts was notable: flavonoid content in the herb extracts was 3.61 to 5.46 per cent, but only 0.13 to 0.21 per cent in the root extracts.

Compound class	Main representatives	Occurrence
Hydroxycinnamic acids	Rosmarinic acid, chlorogenic acid, caffeic acid, 3,4-dicaffeoylquinic acid	Herb and root; rosmarinic acid the main component in each
Triterpene saponins	Saniculosides A–D and N, saniculasaponins (aglycones A1- and R1-barrigenol)	Herb and root; older reference data cite roughly 3–6 % depending on plant part
Flavonoids	Quercetin, isoquercetin, rutin, apigenin, astragalin	Markedly higher in the herb than in the root
Tannins	Epicatechin gallate, gallocatechin	Both plant parts, proportionally higher in the root
Others	Sugars (including sucrose), organic acids, coumarin, essential oil, allantoin	Sugars in fact make up the largest fraction of the extracts by quantity

Why the root in particular has a mistaken-identity problem

The Vienna study had a second, almost detective-like motive. In Austrian colloquial usage, "Radix Saniculae" does not necessarily mean sanicle root at all. Dialect names such as "Saunigl", "Scharnikel" or "Schanikel" refer in many places to an entirely different plant: drooping bittercress (Cardamine enneaphyllos), a member of the cabbage family. Specialists pointed out this naming confusion as early as 1904 and 1929 – little has changed since.

The analysis shows how far apart the two are: while sanicle carries hydroxycinnamic acids and saponins, bittercress contains glucosinolates and their breakdown products sisymbrin and cleomin – a compound class from an entirely different biochemical world. The only notable thing they share is a high sugar content. In practical terms this means that for wild-collected or informally traded material, botanical identity testing is not a formality. The Vienna group established simple chromatographic procedures for exactly this purpose. Contamination of sanicle products with great masterwort (Astrantia major) has also been described.

What research observes regarding inflammation and wound healing

The experimental evidence base is modest, but it is moving – and it is not free of contradictions.

In a broad Austrian screening of 71 traditionally used herbal drugs (cell experiment, in vitro), dichloromethane and methanol extracts of sanicle root showed a moderate to marked reduction in the expression of inflammatory mediators such as interleukin-8 and E-selectin in endothelial cells after these had been stimulated with TNF-α or bacterial lipopolysaccharide.

An earlier cell experiment on 3T3 fibroblasts, by contrast, found no evidence that sanicle herb extract accelerated wound closure; the authors instead observed cytotoxic effects at the wound margin and interpreted the result in the direction of wound debridement rather than tissue regeneration. This finding still stands unresolved alongside the newer animal data.

Because in 2025 the Ukrainian-Estonian group presented the first pharmacological screening in an animal model. In a paw oedema model in rats (animal study, six animals per group, 100 mg/kg) all four extracts tested reduced oedema formation; after five hours the aqueous herb extract reached 36.4 per cent inhibition compared with 29.4 per cent for the reference substance quercetin. In a bleeding time model in guinea pigs, topically applied herb extracts shortened bleeding duration by roughly 48 to 50 per cent versus the untreated control, while the plant-based reference preparation reached 23 per cent. In wound planimetry, incision wounds closed after 8 to 10 days under herb extract, after 10 to 11 days under the reference preparation, and only after 15 to 16 days in the control group. In the agar diffusion test (in vitro) the extracts inhibited growth of E. coli, S. aureus, S. epidermidis, P. aeruginosa and P. vulgaris with inhibition zone diameters between 11 and 15 millimetres – although one extract had no effect at all against two of the organisms.

The authors themselves place their findings in careful context: small group sizes, no cell assays to elucidate mechanism, no toxicity testing. This is a screening that indicates a direction – not a demonstration of efficacy. Clinical trials in humans are entirely absent for sanicle.

Antiviral observations from the laboratories of the 1990s

One small, self-contained strand of research came out of Turkish-Japanese collaboration. In cell experiments (in vitro), leaf extracts of sanicle inhibited the multiplication of influenza viruses and of human parainfluenza virus type 2 respectively. In parallel, during the search for antivirally active constituents, the triterpene saponin saniculoside N was isolated and structurally elucidated; the authors identified rosmarinic acid, however, as the leading active substance of the extract by quantity. These studies are around three decades old and were never carried forward into an animal model, let alone a clinical trial – they remain a laboratory finding.

How sanicle is used traditionally and classified by regulators

Traditional uses differ considerably by region. In Austrian folk tradition, documented in the VOLKSMED database, the herb was brewed as a tea for rinsing and bathing wounds or applied fresh; rhizome and roots were worked into an ointment with lard or butter. In Switzerland and southern Germany, use as a gargle preparation is recorded. Ethnobotanical reviews cite use for poorly healing wounds in the Czech Republic, respiratory complaints in the Caucasus, skin concerns in Bulgaria, coughs in Romania and internal bleeding in the Netherlands.

The regulatory picture is clearly defined and at the same time modest. Germany's Commission E published a positive monograph on Saniculae herba in 1986 for mild catarrh of the respiratory tract, with a daily dose of 4 to 6 grams of the dried herb and the attributed properties antibacterial, expectorant and astringent. No monograph from the HMPC of the European Medicines Agency exists to this day, nor an ESCOP monograph. In Ukraine the species is not recognised as an official herbal drug. Sanicle is therefore a plant with a long tradition, selective regulatory recognition in a single country – and without modern clinical substantiation.

Safety and use

For internal use, standard reference works establish no typical adverse effects; a known allergy to the plant counts as a contraindication. In larger amounts, saponins can irritate mucous membranes and trigger gastrointestinal complaints – an effect that applies to saponin-rich herbal drugs generally. Isolated skin irritation reactions have been described following external application of fresh plant material.

No data exist for pregnancy, breastfeeding or children; use is not advisable in these groups. Systematic investigations of interactions are likewise lacking. The shortening of bleeding time observed in animal experiments has never been studied in humans; anyone taking anticoagulant medication should therefore seek medical advice before use. As a member of the Apiaceae, sanicle is also only suitable with caution for people with known cross-allergies to this family, such as celery or carrot.

Self-collection deserves a point of its own. The Apiaceae include some of the most toxic plants in Central Europe, and in its vegetative state sanicle resembles several woodland species. Anyone without reliable species identification skills should fall back on tested material from a reputable supplier.

Conclusion: a rediscovered plant with an outstanding account

Sanicle is a good example of how unevenly traditional knowledge and modern evidence can be distributed. The phytochemical side is now solid: rosmarinic acid as the dominant phenolic, barrigenol-type triterpene saponins, a clear profile that shows herb and root to be closely related. On the pharmacological side there are cell experiments and, since 2025, the first controlled animal data on inflammation, bleeding time, wound closure and microbial inhibition – with effects that in individual models even exceeded the reference preparations.

What is missing is the decisive step: studies in humans. Until those exist, sanicle remains a European woodland plant rich in tradition whose reputation is older than the evidence for it. The movement of the past two years is remarkable nonetheless. A plant on which hardly anyone conducted research between 1970 and 2020 has suddenly resurfaced in three independent publications – and the Vienna group has already announced that its next step will be isolating individual constituents and testing them in cell models of wound healing. It may well be that in a few years there will be more to report about the little healer from the beech wood.

This article is for general information only and does not replace medical advice. It is not a recommendation for self-treatment. If you have health concerns, please consult a doctor or a qualified professional at a pharmacy or drugstore.